Abstract
Objective The objective was to conduct a preliminary study to access blink reflex parameters across age using the Eyestat.
Background The blink reflex is a primitive brainstem response to an external stimulus is affected by multiple neurologic disorders, including those that affect the dopaminergic circuit that controls the eyelid. Our laboratory has utilized a potential objective measure to identify concussions within a college aged sport population called Eyestat, which measures changes in blink reflex parameters. Prior research cited significant differences in various blink reflex parameters between active play, concussion, and baseline. However, data with older, non-athlete populations has not defined.
Design/Methods One hundred forty three subjects between the ages of 8–80 participated in this study. Once the subject was seated, the test sequence was initiated, in which the subject placed their face into the mask and 5 random air puffs were applied to the corner of the left or right eyes over a course of 20 seconds. High-speed videography (280 frames/sec.) captured the response of the subject's eyes before and after each stimuli.
Results Description statistics of the data indicated differences across age with the following parameters: Latency (ms): 46.02 (ages 8–21); 47.12 (ages 22–30); 48.96 (ages 31–40); 47.44 (ages 41–50); 55.20 (ages 51–60); and 55.39 (ages 61–80). Oscillations (qty): 14.10 (ages 8–21); 14.25 (ages 22–30); 12.19 (ages 31–40); 12.75 (ages 41–50); 9.98 (ages 51–60); and 9.78 (ages 61–80). Excursions (px): 127.57 (ages 8–21); 137.46 (ages 22–30); 135.34 (ages 31–40); 144.88 (ages 41–50); 147.72 (ages 51–60); and 148.85 (ages 61–80).
Conclusions Although more research is warranted to determine if these differences occur with a larger subject pool, this data substantiates the need for longitudinal assessments of the blink reflex as a potential biomarker, providing a non-invasive assessment of brain health in various populations.
Footnotes
Disclosure: Dr. Garner has received stock or an ownership interest from blinktbi, inc.
- © 2021 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Costs and Utilization of New-to-Market Neurologic Medications
Dr. Robert J. Fox and Dr. Mandy Leonard